10-Q: Mannatech Reports Q1 2025 Loss Amidst Sales Decline

Mannatech, Incorporated reports a net loss for Q1 2025 due to a decrease in net sales, primarily driven by weakened economic conditions in Asia.

Summary

• Mannatech, Incorporated reported a net loss of $1.53 million for the quarter ended March 31, 2025, compared to a net income of $1.18 million for the same period in 2024.
• Net sales decreased by 9.6% to $26.563 million from $29.393 million year-over-year.
• The decline in revenue was primarily attributed to slowing demand in Asia due to weakened economic conditions.
• The company experienced a net realized and unrealized foreign currency loss of $0.4 million, compared to a gain of $0.9 million in the previous year.
• Basic and diluted loss per share was $0.80, compared to earnings per share of $0.63 in Q1 2024.
• The company's gross profit decreased by 14.6% to $19.736 million.
• Selling and administrative expenses decreased by 5.4% to $10.016 million.
• As of March 31, 2025, cash and cash equivalents totaled $9.3 million.
• The company had approximately 129,000 active associates and preferred customer positions as of March 31, 2025, compared to 143,000 in the prior year.

Sentiment

Score: 3

Explanation: The document presents a negative outlook due to decreased sales, a net loss, and concerns about future performance and market conditions.

Positives

• Selling and administrative expenses decreased by $0.6 million, or 5.4%, to $10.0 million.
• EMEA net sales increased by $0.1 million, or 4.8%, to $2.2 million.

Negatives

• Net sales in the Americas decreased by $1.2 million, or 11.8%, to $9.0 million.
• Asia/Pacific net sales decreased by $1.7 million, or 9.9%, to $15.4 million.
• Gross profit decreased by $3.4 million, or 14.6%, to $19.7 million.
• The company reported a net loss of $1.53 million, compared to a net income of $1.18 million in the same period last year.

Risks

• Changes in trade policies, including tariffs, could adversely affect the company's cost structure and profitability.
• The company's liquidity is dependent on its ability to maintain and/or continue to improve revenue as compared to its operational expenses.
• If the company's reorganization plans are not successful, or if it experiences further disruption in its supply chain, sales and overall liquidity could be negatively impacted.
• Failure to maintain compliance with Nasdaq Marketplace Rules could adversely impact future access to capital markets.

Future Outlook

The company's future performance is dependent on its ability to maintain or improve revenue compared to operational expenses, and the success of its reorganization plans focusing on revenue growth, margin improvement, and cost control.

Management Comments

• The decline in revenues was principally due to slowing demand in Asia due to weakened economic conditions, relative to the prior year.

Industry Context

The company operates in the competitive nutritional supplements, skin care, and weight-management products industry, utilizing a network marketing distribution channel.

Comparison to Industry Standards

• It is difficult to compare Mannatech's results directly to industry standards without specific competitor data.
• Companies like Herbalife, Nu Skin, and USANA also operate in the direct selling and nutritional supplement space, but their Q1 2025 results would be needed for a relevant comparison.
• Key metrics to compare would include revenue growth, gross margin, operating expenses as a percentage of revenue, and active distributor counts.

Related Party Transactions

• On April 23, 2024, the Company entered into unsecured Loan and Promissory Note agreements with three related parties, who are members of the Company's Board of Directors, and who are current stockholders of the Company, in an aggregate principal amount of $3.6 million.

Stakeholder Impact

• Shareholders may be concerned about the net loss and decreased sales.
• Associates may be affected by changes in the compensation plan and the overall performance of the company.
• Customers may be impacted by potential price increases and changes in product availability.

Next Steps

• The company plans to focus on revenue growth, margin improvement, and cost control through a business reorganization plan.
• The company will continue to monitor its compliance with Nasdaq continued listing rules.

Key Dates

Keywords

Mannatech, net sales, net loss, financial results, Q1 2025, nutritional supplements, direct selling, Asia Pacific, commissions, incentives